| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ANTARES PHARMA, INC. | Director | Common Stock | 0 | $5.60 | 24 May 2022 | Direct | |
| ANTARES PHARMA, INC. | Director | Stock Option (right to buy) | 0 | 24 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322019792-jacob-leonard-s-2022-05-24 | ANTARES PHARMA, INC. | 24 May 2022 | 10 | -$955,220 | 4 | Director | 26 May 2022, 17:26 |
| /report/000101616922000010-jacob-leonard-s-2021-12-31 | ANTARES PHARMA, INC. | 31 Dec 2021 | 1 | $0 | 5 | Director | 04 Feb 2022, 18:09 |
| /report/000101616921000005-jacob-leonard-s-2021-08-27 | ANTARES PHARMA, INC. | 27 Aug 2021 | 3 | +$0.96 | 4 | Director | 31 Aug 2021, 18:26 |
| /report/000120919121040336-jacob-leonard-s-2021-06-10 | ANTARES PHARMA, INC. | 10 Jun 2021 | 2 | +$139,999 | 4 | Director | 14 Jun 2021, 18:24 |